Butterfly Network (BFLY) Total Non-Current Liabilities (2020 - 2026)

Butterfly Network (BFLY) reported Total Non-Current Liabilities of $86.2 million for Q1 2026, up 23.48% on a YoY basis from $69.8 million in Q1 2025, and down 6.51% sequentially from $92.2 million in Q4 2025.

Butterfly Network (BFLY) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Butterfly Network (BFLY) has 7 years of Total Non-Current Liabilities data on file, last reported at $86.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 23.48% year-over-year to $86.2 million; the trailing twelve-month figure through Mar 2026 stood at $86.2 million (up 23.48% YoY), and the FY2025 full-year result was $92.2 million, up 17.32% from the prior year.
  • Total Non-Current Liabilities retreated to $86.2 million in Q1 2026, from $92.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $121.9 million in Q1 2022 to a low of $69.8 million in Q1 2025.
  • A 5-year average of $84.4 million and a median of $78.6 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Peak annual rise in Total Non-Current Liabilities reached 37.0% in 2022, while the deepest fall reached 41.73% in 2022.
  • Tracing BFLY's Total Non-Current Liabilities over 5 years: stood at $91.6 million in 2022, then declined by 17.79% to $75.3 million in 2023, then grew by 4.36% to $78.6 million in 2024, then climbed by 17.32% to $92.2 million in 2025, then dropped by 6.51% to $86.2 million in 2026.
  • Business Quant data shows BFLY's Total Non-Current Liabilities at $86.2 million in Q1 2026, $92.2 million in Q4 2025, and $76.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 183.94 Bn 176.64 Bn 6.27 Bn -
2 Stryker 128.78 Bn 125.90 Bn 3.81 Bn 20.94 Bn
3 Medtronic 109.01 Bn 99.79 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 68.59 Bn 67.13 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 47.66 Bn 43.99 Bn 1.29 Bn 2.64 Bn
6 GE HealthCare Technologies 28.36 Bn 26.07 Bn 1.98 Bn 24.21 Bn
7 Dexcom 28.30 Bn 27.18 Bn 750.30 Mn 3.53 Bn
8 Smith & Nephew 26.93 Bn 26.36 Bn - 3.57 Bn
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn 9.85 Bn
10 Butterfly Network 1.76 Bn 1.62 Bn 18.29 Mn 86.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.23 Mn
Dec 31, 2025 92.23 Mn
Sep 30, 2025 76.65 Mn
Jun 30, 2025 70.99 Mn
Mar 31, 2025 69.83 Mn
Dec 31, 2024 78.61 Mn
Sep 30, 2024 72.51 Mn
Jun 30, 2024 78.37 Mn
Mar 31, 2024 72.04 Mn
Dec 31, 2023 75.33 Mn
Sep 30, 2023 75.36 Mn
Jun 30, 2023 85.52 Mn
Mar 31, 2023 79.96 Mn
Dec 31, 2022 91.62 Mn
Sep 30, 2022 99.00 Mn
Jun 30, 2022 109.25 Mn
Mar 31, 2022 121.93 Mn
Dec 31, 2021 98.05 Mn
Sep 30, 2021 72.26 Mn
Jun 30, 2021 182.63 Mn